By ANDREW POLLACK
The drug, Praluent, developed by Sanofi and Regeneron, is expected to become the next flashpoint in the growing controversy of escalating pharmaceutical price.
Published: July 25, 2015 at 12:00AM
from NYT Business Day http://ift.tt/1fspKB1